GENFIT (EPA:GNFT) | Finanzwire

BRIEF

published on 11/02/2026 at 07:35, 4 days 12 hours ago

GENFIT highlights its innovations at the Liver Meeting 2026

GENFIT ACLF Liver Meeting 2026 MASH Diagnosis NIS™ Technologies
BRIEF

published on 11/02/2026 at 07:35, 4 days 12 hours ago

GENFIT Highlights Advances in ACLF and MASH Diagnostics at AASLD 2026

Diagnostics GENFIT ACLF MASH Nangibotide
PRESS RELEASE

published on 11/02/2026 at 07:30, 4 days 12 hours ago

GENFIT to Highlight Progress in ACLF and MASH Diagnostics at AASLD The Liver Meeting® 2026
BRIEF

published on 09/28/2026 at 19:56, 1 month 8 days ago

GENFIT Announces H1 2026 Financial Performance and Strategic Developments

R&D Pipeline GENFIT Financials Biopharmaceutical Developments MASH Diagnostics Ipsen Agreement
PRESS RELEASE

published on 09/28/2026 at 19:51, 1 month 8 days ago

GENFIT Reports First-Half 2026 Financial Results and Provides Corporate Update
GENFIT reports first-half 2026 financial results and provides corporate update including significant revenue growth, strategic developments and future milestones

Revenues Financial Results Corporate Update Milestones GENFIT
BRIEF

published on 09/14/2026 at 18:20, 1 month 22 days ago

GENFIT Initiates Phase 2 Trials for Nangibotide in ACLF

Phase 2 Trials Liver Diseases GENFIT ACLF Nangibotide
PRESS RELEASE

published on 09/14/2026 at 18:15, 1 month 22 days ago

GENFIT Advances Nangibotide in Phase 2 Clinical Investigation in ACLF
GENFIT strengthens pipeline with acquisition of nangibotide for ACLF treatment in Phase 2 trial. Positive efficacy and safety signals observed. Details at The Liver Meeting in Denver, November 2026

Phase 2 Trial GENFIT ACLF Nangibotide The Liver Meeting
BRIEF

published on 09/11/2026 at 07:35, 1 month 25 days ago

GENFIT Joins CAC Mid 60 and SBF 120 Indices

Institutional Investors Market Capitalization SBF 120 CAC Mid 60 GENFIT Inclusion
BRIEF

published on 09/11/2026 at 07:35, 1 month 25 days ago

GENFIT is included in the CAC Mid 60 and SBF 120 indices

Biopharmaceutical SBF 120 GENFIT CAC Mid 60 Stock Market Indices
PRESS RELEASE

published on 09/11/2026 at 07:30, 1 month 25 days ago

GENFIT to Join CAC Mid 60 and SBF 120 Indices on Euronext Paris
GENFIT to join CAC Mid 60 and SBF 120 indices on Euronext Paris after annual review, enhancing visibility and market profile. CEO Pascal Prigent confirms company's commitment to innovative therapies and long-term value creation

Euronext Paris Biopharmaceutical SBF 120 GENFIT CAC Mid 60

1 2 ... 8

Published on 11/06/2026 at 13:00, 7 hours 4 minutes ago

Alaska Energy Metals Achieves High Extraction Rates of Metals from Hydromet Testing, Nikolai Nickel Project, Alaska
Published on 11/06/2026 at 12:30, 7 hours 34 minutes ago

Relevant Gold Receives Expanded Drilling Approvals for the Lewiston Project in Wyoming
Published on 11/06/2026 at 12:30, 7 hours 34 minutes ago

Vogenx Reports Third Quarter 2026 Financial Results and Business Highlights
Published on 11/06/2026 at 10:00, 10 hours 4 minutes ago

Mongolia Tax Audit
Published on 11/06/2026 at 05:15, 14 hours 49 minutes ago

Valeo and QNX Unveil A New Smart Camera Platform at CIIE, Secures Multiple Design Wins

View all ACCESSWIRE

Published on 11/06/2026 at 19:15, 48 minutes ago

EQS-Adhoc: ABO Energy GmbH & Co. KGaA suspends the interest payment on the bond 2024/2029 due on 8 November 2026.
Published on 11/06/2026 at 19:00, 1 hour 3 minutes ago

Finexity AG: FINEXITY issues 2026/2030 bond with a minimum of 7.00% p.a. – either conventionally in a securities account or as a crypto security in a wallet
Published on 11/06/2026 at 18:32, 1 hour 31 minutes ago

EQS-Adhoc: Finexity AG: FINEXITY issues 2026/2030 bond
Published on 11/06/2026 at 18:00, 2 hours 3 minutes ago

ARVERNE GROUP: Number shares and voting rights
Published on 11/06/2026 at 17:41, 2 hours 22 minutes ago

Turkiye Garanti Bankasi A.S.: Daily Share Buyback Transactions

View all EQS

Published on 11/06/2026 at 18:00, 2 hours 4 minutes ago

ICADE - PR - S&P credit rating
Published on 11/06/2026 at 18:00, 2 hours 4 minutes ago

DISCLOSURE OF SHARE CAPITAL AND VOTING RIGHTS
Published on 11/06/2026 at 17:54, 2 hours 9 minutes ago

Disclosure of Share Capital and Voting Rights as of October 31, 2026
Published on 11/06/2026 at 17:35, 2 hours 29 minutes ago

Disclosure of the number of shares and the total number of voting rights as of October 31, 2026
Published on 11/06/2026 at 11:05, 8 hours 58 minutes ago

voting rights

View all LES ECHOS COMFI WIRE

News